Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs56177071 | chr7:105165648 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs56186790 | chr19:52784806 | G/A | 0.00035 | 174 | 25.47 | 28.3 | 18.2 | KM Plot |
PCPG | rs56190599 | chr10:50588867 | G/A | 4.44E-6 | 174 | 24.53 | 34.93 | 25.17 | KM Plot |
PCPG | rs56197902 | chr10:50527390 | G/GA | 6.45E-6 | 171 | 24.7 | 31.9 | 25.17 | KM Plot |
PCPG | rs56203859 | chr10:50553146 | T/C | 3.73E-6 | 177 | 24.53 | 34.37 | 25.17 | KM Plot |
PCPG | rs56222435 | chr17:50297907 | A/G | 5.9E-5 | 177 | 25.4 | 28.47 | 14.47 | KM Plot |
PCPG | rs56230603 | chr7:105165268 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs56239334 | chr7:105165351 | G/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs56241013 | chr2:242185311 | T/C | 5.62E-5 | 173 | 24.17 | 32.92 | 9.13 | KM Plot |
PCPG | rs56244291 | chr2:241526167 | G/A | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs56251768 | chr7:105165591 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs56266892 | chr1:244155156 | T/C | 0.000381 | 171 | 27.95 | 20.17 | 15.8 | KM Plot |
PCPG | rs56268110 | chr7:105166712 | T/C | 6.1E-5 | 177 | 20.2 | 28.95 | 2.28 | KM Plot |
PCPG | rs56272125 | chr11:18139967 | G/T | 4.13E-6 | 176 | 27.2 | 23.48 | 10.3 | KM Plot |
PCPG | rs56288505 | chr11:46272263 | G/A | 0.000108 | 173 | 25.6 | 25.57 | 25.4 | KM Plot |